John Baumann

Jul 23, 2024 | drugdiscoveryonline.com | Vincenzo Gioia |David Lyon |Molly Adam |John Baumann

Webinar: Innovative AI-Driven Solutions to Address the Growing Complexity of APIsDiscover CASP technologies - the award-winning AI and vast data that propel Lonza’s leading predictive retrosynthesis technology, used to mitigate the impact of rising small mol API complexity and its resulting longer syntheses.

Feb 23, 2024 | drugdeliveryleader.com | John Baumann

By John Baumann, head of R&D Advanced Engineering Technologies – Small Molecule, Lonza Spray drying of amorphous dispersions improves solubility and bioavailability that enables supersaturation in the intestine, driving higher rates of absorption when compared to crystalline drug forms.

Jan 2, 2024 | drugdiscoveryonline.com | Shalini Nagar |John Baumann

Biochips are small medical devices with microarrays for carrying out biochemical processes. Biosensors enable the screening of different biological materials such as enzymes, proteins, DNA, biological molecules, and more, and are used in drug discovery and research. They can also be implanted in the body for targeted drug delivery or to track health data.

Sep 13, 2023 | outsourcedpharma.com | Kriti Khandelwal |Manjari Palla |Ramesh Mullangi |John Baumann |Louis Garguilo

Is the growing demand for small molecule outsourcing impeding your ability to find a reliable partner with capacity? Don’t miss Outsourced Pharma Capacity Update — a virtual event focused entirely on the available capacity and related service area capabilities, volumes, locations, and facilities of CDMOs. This multiday event is conveniently grouped by molecule type and will feature small molecule partner presentations on October 4th. Registration is free.